Tag: Akari Therapeutics

December 2, 2019

Akari Therapeutics Announces Phase 3 Trial Design

The company has announced the design of its Phase 3 pediatric trial in HSCT-TMA after an end-of-Phase 2 meeting with...
October 10, 2019

Akari Therapeutics Announces Positive Phase 2 Clinical Data of Nomacopan

The company announced results at the European Academy of Dermatology and Venereology Congress in Madrid, Spain.